Skip to main content

Chronic Pain

33
Pipeline Programs
30
Companies
50
Clinical Trials
5 recruiting
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
12
0
2
0
14
5
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 143 programs with unclassified modality

On Market (1)

Approved therapies currently available

Purdue Pharma
BUTRANSApproved
buprenorphine
Purdue Pharma
Partial Opioid Agonist [EPC]transdermal2010
23M Part D

Competitive Landscape

48 companies ranked by most advanced pipeline stage

Boston Scientific
1
1
Precision Spinal Cord Stimulation SystemPhase 41 trial
Precision SCSPhase 31 trial
Boston Scientific Spectra WaveWriter SCS SystemN/A1 trial
Boston Scientific Spectra WaveWriter™ Spinal Cord StimulationN/A1 trial
Boston Scientific WaveWriter Alpha™ SCS SystemsN/A1 trial
+20 more programs
Active Trials
NCT04231409Terminated41Est. Oct 2020
NCT03689920Completed174Est. Dec 2021
NCT07190807Recruiting70Est. May 2029
+22 more trials
Pfizer
PfizerNEW YORK, NY
7 programs
1
2
1
EMBEDA™Phase 41 trial
ALO-02Phase 31 trial
NSAIDPhase 31 trial
PF-04531083Phase 11 trial
Early interventionN/A1 trial
+2 more programs
Active Trials
NCT04716621Completed528Est. Apr 2016
NCT03425266Completed80Est. Oct 2018
NCT05661760Unknown2,309Est. Dec 2023
+4 more trials
Purdue Pharma
Purdue PharmaCT - Stamford
4 programs
2
1
Oxycodone Naloxone CombinationPhase 41 trial
BuprenorphinePhase 31 trial
Buprenorphine transdermal delivery systemPhase 31 trial
WHTN/A1 trial
Active Trials
NCT03299556Completed420Est. Nov 2019
NCT00531427Completed567Est. Nov 2009
NCT00313833Completed100Est. Nov 2001
+1 more trials
Medtronic
MedtronicNJ - Phillipsburg
3 programs
1
HydrocodonePhase 41 trial
Medtronic Intellis™ and Vanta™N/A1 trial
Medtronic PSR TDD PMCFN/A1 trial
Active Trials
NCT04725838Completed255Est. Jul 2023
NCT04714385Completed209Est. Jan 2024
NCT01517295Completed30Est. Sep 2012
Innovation Pharmaceuticals
6 programs
2
KetaminePhase 31 trial
Opioids taper offPhase 31 trial
Early interventionN/A
Self-administered psychosocial intervention delivered via smartphone.N/A1 trial
Transcranial electrical stimulationN/A1 trial
+1 more programs
Active Trials
NCT06765200Not Yet Recruiting195Est. Dec 2027
NCT05099406Unknown120Est. May 2023
NCT02601755Completed302Est. Aug 2023
+2 more trials
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
5 programs
5
Tramadol HCl ERPhase 31 trial
Tramadol HCl ERPhase 31 trial
Tramadol HCl ERPhase 31 trial
tramadol ERPhase 31 trial
tramadol HCl ER; celecoxibPhase 3Small Molecule1 trial
Active Trials
NCT00325858Completed1,000Est. Dec 2003
NCT00348010Completed245Est. Jul 2001
NCT00347724Completed600Est. Nov 2001
+2 more trials
Oregon Therapeutics
1
1
CORPs InterventionPhase 31 trial
In-vivo pain catastrophizing inductionPhase 11 trial
Problem-Solving Skills TrainingN/A1 trial
Active Trials
NCT01496378Completed122Est. Mar 2015
NCT00677911Completed47Est. Dec 2007
NCT06091202Recruiting608Est. Jun 2027
Piramal Pharma
Piramal PharmaMumbai, India
1 program
1
Hydromorphone HydrochloridePhase 31 trial
Active Trials
NCT01709747Completed364Est. Feb 2018
Aurora Oncology
1
MRCP001Phase 21 trial
Active Trials
NCT03522467Unknown40Est. Sep 2020
Biocorp
1 program
1
THC and CDB in a 1 to 1 ratioPhase 21 trial
Active Trials
NCT03337503Terminated161Est. Feb 2019
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
6 programs
6
AZD1386Phase 11 trial
AZD1386Phase 11 trial
AZD2066Phase 11 trial
MEDI0618Phase 11 trial
MEDI0618Phase 11 trial
+1 more programs
Active Trials
NCT00690079Completed69Est. Oct 2008
NCT00736658Completed32Est. Sep 2008
NCT00930306Completed15Est. Sep 2009
+3 more trials
Centrexion Therapeutics
2
CNTX-6016Phase 11 trial
CNTX-6970Phase 11 trial
Active Trials
NCT04154501Completed68Est. Aug 2019
NCT03787004Completed62Est. Sep 2018
Lohocla Research Corporation
1
Kindolor TosylatePhase 11 trial
Active Trials
NCT06243835Terminated16Est. Feb 2025
Neuronoff
NeuronoffOH - Cleveland
1 program
1
PNS Injectrode F1Phase 11 trial
Active Trials
NCT06206356Completed10Est. Mar 2024
Abbott
AbbottABBOTT PARK, IL
16 programs
Abbott SCS SystemsN/A1 trial
AccelerometryN/A1 trial
AwakeN/A1 trial
Burst and Tonic stimulationN/A1 trial
Burst-capable SCS systemN/A1 trial
+11 more programs
Active Trials
NCT05659836Completed28Est. Jun 2023
NCT02950831Completed27Est. Mar 2018
NCT02284542Completed34Est. Jan 2017
+13 more trials
Saluda Medical
Saluda MedicalAustralia - Macquarie Park
9 programs
APMN/A1 trial
Evoke Spinal Cord StimulationN/A1 trial
Evoke Spinal Cord StimulationN/A1 trial
Evoke Spinal Cord StimulationN/A1 trial
Evoke Spinal Cord StimulationN/A1 trial
+4 more programs
Active Trials
NCT06057480Completed30Est. Dec 2024
NCT06229470Active Not Recruiting250Est. Feb 2027
NCT04319887Completed300Est. Dec 2023
+6 more trials
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
9 programs
Acceptance and Commitment TherapyN/A1 trial
Cannabis EdibleN/A1 trial
MY-SKILLS - onlineN/A1 trial
Open-Label Placebo Treatment for Chronic Back PainN/A1 trial
PNSN/A1 trial
+4 more programs
Active Trials
NCT03661840Completed50Est. Mar 2021
NCT03522324Completed268Est. Oct 2023
NCT03440320Completed32Est. May 2021
+6 more trials
Spine BioPharma
Spine BioPharmaNY - New York
3 programs
BioWaveN/A
Muse-S headband; InteraXon Inc., RRID:SCR_014418N/A1 trial
Neurofeedback trainingN/A1 trial
Active Trials
NCT04944459Completed50Est. Oct 2023
NCT04418362Completed20Est. Jul 2021
Sound Pharmaceuticals
Cognitive Behavioral TherapyN/A1 trial
PsychoEducationN/A1 trial
Resilience and Well-Being ProgramN/A1 trial
Active Trials
NCT05699252Active Not Recruiting331Est. Feb 2027
NCT02653664Completed343Est. Mar 2020
NCT03563820Completed7Est. May 2019
Human BioSciences
Human BioSciencesWV - Martinsburg
3 programs
Empowered ReliefN/A1 trial
Pharmacogenetic testingN/A1 trial
Telephone-Delivered Intervention 1N/A1 trial
Active Trials
NCT07090018Enrolling By Invitation60Est. Dec 2026
NCT05966142Completed1,048Est. May 2024
NCT00663663Completed207Est. Jun 2013
Teva
TevaIsrael - Petach Tikva
3 programs
Fentanyl Buccal TabletPHASE_33 trials
Fentanyl Buccal Tablets Compared With Immediate-Release OxycodonePHASE_31 trial
Hydrocodone ERPHASE_31 trial
Active Trials
NCT04635852Completed10Est. Dec 2014
NCT00842829Terminated330Est. May 2011
NCT00813488Completed213Est. Jan 2010
+2 more trials
Forte Biosciences
Acceptance and Commitment TherapyN/A1 trial
interdisciplinary treatmentN/A1 trial
Active Trials
NCT06981312Recruiting150Est. Dec 2027
NCT04598373Completed25,000Est. Dec 2016
Alliance Pharmaceuticals
2 programs
BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for PainN/A1 trial
Our Whole LivesN/A1 trial
Active Trials
NCT01186341Completed418Est. Jun 2011
NCT06515925Recruiting212Est. Nov 2025
T-Therapeutics
2 programs
Digital CBT-IN/A1 trial
Long-term Monitoring of Sleep with Ear-EEG in Patients with Chronic PainN/A1 trial
Active Trials
NCT06361914Active Not RecruitingEst. Dec 2026
NCT06368531CompletedEst. Nov 2024
Flowonix Medical
Flowonix MedicalNJ - Hackettstown
2 programs
Prometra Programmable Intrathecal Infusion PumpN/A1 trial
Prometra II Programmable Pump systemPHASE_41 trial
Active Trials
NCT01854229Completed400Est. Mar 2023
NCT03876158Withdrawn0Est. Jun 2022
GE HealthCare
2 programs
[18F]FDGPHASE_11 trial
[18F]FTC-146PHASE_11 trial
Active Trials
NCT03195270Completed88Est. Jan 2022
NCT04435821Completed5Est. Oct 2024
Circle Pharma
Circle PharmaCA - South SF
1 program
APP-led model of care for chronic pain managementN/A1 trial
Active Trials
NCT05336903Completed45Est. Dec 2023
Young BioPharma
Acceptance and Commitment TherapyN/A1 trial
Active Trials
NCT05528536Completed163Est. Jan 2024
BioWave
1 program
BioWaveN/A1 trial
Active Trials
NCT05511181Completed120Est. Jun 2023
PainTEQ
1 program
Clinical Study on a Novel Minimally Invasive Posterior Sacroiliac Fusion DeviceN/A1 trial
Active Trials
NCT04423120Completed159Est. Apr 2023

+18 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Flowonix MedicalPrometra II Programmable Pump system
Purdue PharmaOxycodone Naloxone Combination
MedtronicHydrocodone
PfizerEMBEDA™
TevaFentanyl Buccal Tablet
Boston ScientificPrecision Spinal Cord Stimulation System
Oregon TherapeuticsCORPs Intervention
Innovation PharmaceuticalsKetamine
PfizerNSAID
Piramal PharmaHydromorphone Hydrochloride
PfizerALO-02
TevaHydrocodone ER
UCB PharmaHydrocodone Bitartrate
Innovation PharmaceuticalsOpioids taper off
TevaFentanyl Buccal Tablet

Showing 15 of 50 trials with date data

Clinical Trials (50)

Total enrollment: 13,356 patients across 50 trials

NCT03876158Flowonix MedicalPrometra II Programmable Pump system

Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS)

Start: Oct 2019Est. completion: Jun 20220
Phase 4Withdrawn
NCT03179475Purdue PharmaOxycodone Naloxone Combination

Targin® for Chronic Pain Management in Patients With Spinal Cord Injury

Start: Sep 2019Est. completion: Nov 20211 patients
Phase 4Completed

Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients

Start: Feb 2012Est. completion: Sep 201230 patients
Phase 4Completed

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Start: Apr 2010Est. completion: Mar 201114 patients
Phase 4Terminated
NCT00842829TevaFentanyl Buccal Tablet

Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Start: Jan 2009Est. completion: May 2011330 patients
Phase 4Terminated
NCT00205868Boston ScientificPrecision Spinal Cord Stimulation System

Spinal Cord Stimulation for Low Back Pain

Start: Dec 2004Est. completion: Dec 2007304 patients
Phase 4Completed

Tele-Collaborative Outreach to Rural Patients With Chronic Pain

Start: Jul 2024Est. completion: Jun 2027608 patients
Phase 3Recruiting

Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain

Start: May 2017Est. completion: Sep 2019106 patients
Phase 3Completed

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Start: Jul 2015Est. completion: Feb 20193,021 patients
Phase 3Completed
NCT01709747Piramal PharmaHydromorphone Hydrochloride

Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration

Start: Jun 2013Est. completion: Feb 2018364 patients
Phase 3Completed

A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain

Start: Jun 2012Est. completion: Jun 2013410 patients
Phase 3Completed
NCT01223365TevaHydrocodone ER

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

Start: Oct 2010Est. completion: Sep 2012330 patients
Phase 3Completed
NCT01115569UCB PharmaHydrocodone Bitartrate

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

Start: May 2010Est. completion: Jan 2012424 patients
Phase 3Completed

Cognitive Function and Addiction Under Opioid Tapering

Start: Feb 2009Est. completion: Dec 201475 patients
Phase 3Completed
NCT00813488TevaFentanyl Buccal Tablet

Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

Start: Dec 2008Est. completion: Jan 2010213 patients
Phase 3Completed

Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee

Start: Sep 2007Est. completion: Nov 2009567 patients
Phase 3Completed
NCT00463047TevaFentanyl Buccal Tablets Compared With Immediate-Release Oxycodone

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain

Start: Jul 2007Est. completion: Feb 2009323 patients
Phase 3Completed

An Implantable Spinal Cord Stimulation Pain Management System

Start: Feb 2003Est. completion: Mar 200565 patients
Phase 3Completed
NCT00348452Bausch Healthtramadol HCl ER; celecoxib

A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA)

Start: Sep 2002Est. completion: Aug 20031,000 patients
Phase 3Completed

A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip

Start: Jan 2002Est. completion: Dec 20031,000 patients
Phase 3Completed
NCT00313833Purdue PharmaBuprenorphine transdermal delivery system

Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.

Start: Dec 2000Est. completion: Nov 2001100 patients
Phase 3Completed

A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the Knee

Start: Nov 2000Est. completion: Jul 2001245 patients
Phase 3Completed

A Study Comparing the Effectiveness and Safety of Extended-release Tramadol Versus Placebo in the Treatment of Chronic Low Back Pain

Start: Nov 2000Est. completion: Nov 2001600 patients
Phase 3Completed

A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.

Start: Oct 2000Est. completion: Feb 2003650 patients
Phase 3Completed

Cannabis Oil for Pain Effectiveness

Start: Jul 2018Est. completion: Sep 202040 patients
Phase 2Unknown
NCT03337503BiocorpTHC and CDB in a 1 to 1 ratio

Safety and Efficacy of Medical Cannabis Oil in the Treatment of Patients with Chronic Pain

Start: Jan 2018Est. completion: Feb 2019161 patients
Phase 2Terminated
NCT04635852TevaFentanyl Buccal Tablet

Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients

Start: Mar 2013Est. completion: Dec 201410 patients
Phase 2Completed

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Start: Oct 2025Est. completion: Sep 202930 patients
Phase 1/2Not Yet Recruiting

A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults

Start: Apr 2024Est. completion: Feb 202516 patients
Phase 1Terminated
NCT06206356NeuronoffPNS Injectrode F1

Lumbar Injectrode Feasibility Evaluation

Start: Jan 2024Est. completion: Mar 202410 patients
Phase 1Completed

Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Start: Dec 2022Est. completion: Dec 202336 patients
Phase 1Completed

PET/MRI in the Diagnosis of Pediatric Chronic Pain

Start: Nov 2020Est. completion: Oct 20245 patients
Phase 1Completed

A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Start: Nov 2019Est. completion: Feb 202264 patients
Phase 1Completed

A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects

Start: Dec 2018Est. completion: Aug 201968 patients
Phase 1Completed

A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects

Start: Aug 2017Est. completion: Sep 201862 patients
Phase 1Completed
NCT02508155AstraZenecaMEDI7352 for IV infusion

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

Start: Nov 2015Est. completion: Dec 2020132 patients
Phase 1Completed

Use of PET/MR Imaging in Chronic Pain

Start: Nov 2014Est. completion: Jan 202288 patients
Phase 1Completed

A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.

Start: May 2010Est. completion: Jul 201024 patients
Phase 1Completed

AZD2066 Cocktail Study

Start: Jun 2009Est. completion: Sep 200915 patients
Phase 1Completed

AZD1386 Japanese Multiple Ascending Dosing Study

Start: Jun 2008Est. completion: Sep 200832 patients
Phase 1Completed

Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386

Start: Feb 2008Est. completion: Oct 200869 patients
Phase 1Completed
NCT00677911Oregon TherapeuticsIn-vivo pain catastrophizing induction

Immunologic Response to Negative Cognition in Persons With Chronic Pain

Start: Feb 2007Est. completion: Dec 200747 patients
Phase 1Completed
NCT07137715Colorado TherapeuticsPain reprocessing therapy

Psychological Options for Wellness and Recovery (POWeR) Trial for Veterans With Chronic Back/Neck Pain

Start: Mar 2026Est. completion: Sep 2028360 patients
N/ARecruiting
NCT07267715Saluda MedicalSpinal Cord Stimulation

EVA: Evaluation of EVOKE Therapy Metrics Generated Using the Evoke System With EVA

Start: Nov 2025Est. completion: Nov 202640 patients
N/ANot Yet Recruiting
NCT07190807Boston ScientificBoston Scientific WaveWriter Alpha™ SCS Systems

Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control

Start: Nov 2025Est. completion: May 202970 patients
N/ARecruiting
NCT06765200Innovation PharmaceuticalsSelf-administered psychosocial intervention delivered via smartphone.

Effectiveness of a Digital Treatment for Adolescents with Chronic Pain

Start: Oct 2025Est. completion: Dec 2027195 patients
N/ANot Yet Recruiting

Empowered Relief: A One-Time Session to Help Postpartum Women Manage Ongoing Pain After Cesarean Delivery

Start: Sep 2025Est. completion: Dec 202660 patients
N/AEnrolling By Invitation
NCT06940986Utah MedicalEmpowered Relief

The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System

Start: Aug 2025Est. completion: Jul 2028608 patients
N/ANot Yet Recruiting
NCT07033195Colorado TherapeuticsSkills-based Virtual Reality Therapy

Virtual Reality Treatment for Adults With Chronic Back Pain (VRNT)

Start: Jun 2025Est. completion: May 2027200 patients
N/ARecruiting

Comparison of the Efficacy of an Empowered Relief Single-Session Versus Standard Care for Reducing Postoperative Pain Following Elective Orthopedic Surgery: A Randomized Controlled Trial

Start: May 2025Est. completion: Sep 2027134 patients
N/ARecruiting

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

14 late-stage (Phase 3) programs, potential near-term approvals
5 actively recruiting trials targeting 13,356 patients
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.